| Deborah Goddard, MD | |
|
340 Maple St, Suite 203, Marlborough, MA 01752-3200 | |
| (508) 485-7779 | |
| (508) 485-7769 |
| Full Name | Deborah Goddard |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 19 Years |
| Location | 340 Maple St, Marlborough, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255463733 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 260925 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Newton-wellesley Hospital | Newton, MA | Hospital |
| Massachusetts General Hospital | Boston, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Krauss Dermatology Pc | 6103845094 | 7 |
News Archive
Thermo Fisher Scientific Inc., the world leader in serving science, today reported its financial results for the fourth quarter and full year ended December 31, 2011.
UCLA neuroscience researchers have successfully transferred the memory of one animal to another via injections of RNA. This futuristic study has made possible hopes for similar transfers among higher animals too including humans.
Purdue Pharma L.P. will present data from the clinical program for Butrans™ (buprenorphine) Transdermal System CIII in a series of posters at PAINWeek®2010, September 8-10 in Las Vegas.
United Therapeutics Corporation today announced receipt of a Paragraph IV Certification Notice Letter on February 3, 2012 from Sandoz Inc. advising that Sandoz has submitted an Abbreviated New Drug Application to the U.S. Food and Drug Administration requesting approval to market a generic version of the 10 mg/mL strength of Remodulin (treprostinil) injection.
A comprehensive new Kaiser Family Foundation survey of the experiences of New Orleans residents - the second since Hurricane Katrina - reveals a still-struggling population that gives very mixed reviews in key areas of the recovery efforts. Most residents feel forgotten by the nation and its leaders, yet are still optimistic about their city's future.
› Verified 3 days ago
| Entity Name | Louis Kuchnir Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871709634 PECOS PAC ID: 0143270868 Enrollment ID: O20050131000033 |
News Archive
Thermo Fisher Scientific Inc., the world leader in serving science, today reported its financial results for the fourth quarter and full year ended December 31, 2011.
UCLA neuroscience researchers have successfully transferred the memory of one animal to another via injections of RNA. This futuristic study has made possible hopes for similar transfers among higher animals too including humans.
Purdue Pharma L.P. will present data from the clinical program for Butrans™ (buprenorphine) Transdermal System CIII in a series of posters at PAINWeek®2010, September 8-10 in Las Vegas.
United Therapeutics Corporation today announced receipt of a Paragraph IV Certification Notice Letter on February 3, 2012 from Sandoz Inc. advising that Sandoz has submitted an Abbreviated New Drug Application to the U.S. Food and Drug Administration requesting approval to market a generic version of the 10 mg/mL strength of Remodulin (treprostinil) injection.
A comprehensive new Kaiser Family Foundation survey of the experiences of New Orleans residents - the second since Hurricane Katrina - reveals a still-struggling population that gives very mixed reviews in key areas of the recovery efforts. Most residents feel forgotten by the nation and its leaders, yet are still optimistic about their city's future.
› Verified 3 days ago
| Entity Name | Krauss Dermatology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962524629 PECOS PAC ID: 6103845094 Enrollment ID: O20051121000703 |
News Archive
Thermo Fisher Scientific Inc., the world leader in serving science, today reported its financial results for the fourth quarter and full year ended December 31, 2011.
UCLA neuroscience researchers have successfully transferred the memory of one animal to another via injections of RNA. This futuristic study has made possible hopes for similar transfers among higher animals too including humans.
Purdue Pharma L.P. will present data from the clinical program for Butrans™ (buprenorphine) Transdermal System CIII in a series of posters at PAINWeek®2010, September 8-10 in Las Vegas.
United Therapeutics Corporation today announced receipt of a Paragraph IV Certification Notice Letter on February 3, 2012 from Sandoz Inc. advising that Sandoz has submitted an Abbreviated New Drug Application to the U.S. Food and Drug Administration requesting approval to market a generic version of the 10 mg/mL strength of Remodulin (treprostinil) injection.
A comprehensive new Kaiser Family Foundation survey of the experiences of New Orleans residents - the second since Hurricane Katrina - reveals a still-struggling population that gives very mixed reviews in key areas of the recovery efforts. Most residents feel forgotten by the nation and its leaders, yet are still optimistic about their city's future.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Deborah Goddard, MD 340 Maple St, Suite 203, Marlborough, MA 01752-3200 Ph: (508) 485-7779 | Deborah Goddard, MD 340 Maple St, Suite 203, Marlborough, MA 01752-3200 Ph: (508) 485-7779 |
News Archive
Thermo Fisher Scientific Inc., the world leader in serving science, today reported its financial results for the fourth quarter and full year ended December 31, 2011.
UCLA neuroscience researchers have successfully transferred the memory of one animal to another via injections of RNA. This futuristic study has made possible hopes for similar transfers among higher animals too including humans.
Purdue Pharma L.P. will present data from the clinical program for Butrans™ (buprenorphine) Transdermal System CIII in a series of posters at PAINWeek®2010, September 8-10 in Las Vegas.
United Therapeutics Corporation today announced receipt of a Paragraph IV Certification Notice Letter on February 3, 2012 from Sandoz Inc. advising that Sandoz has submitted an Abbreviated New Drug Application to the U.S. Food and Drug Administration requesting approval to market a generic version of the 10 mg/mL strength of Remodulin (treprostinil) injection.
A comprehensive new Kaiser Family Foundation survey of the experiences of New Orleans residents - the second since Hurricane Katrina - reveals a still-struggling population that gives very mixed reviews in key areas of the recovery efforts. Most residents feel forgotten by the nation and its leaders, yet are still optimistic about their city's future.
› Verified 3 days ago
Dr. Louis Kuchnir, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 340 Maple St Ste 203, Marlborough, MA 01752 Phone: 508-485-7779 | |
Byron Ho, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 201 Boston Post Rd W Ste 200&202, Marlborough, MA 01752 Phone: 508-460-9613 | |
Dr. Kevin Donohue, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 340 Maple St, Marlborough, MA 01752 Phone: 508-485-7779 Fax: 508-485-7769 | |
Carl F Schanbacher, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 340 Maple St, Suite 203, Marlborough, MA 01752 Phone: 508-485-7779 Fax: 508-485-7769 | |
Thanh-nga Trinh Tran, MD, PHD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 340 Maple St., Suite 203, Marlborough, MA 01752 Phone: 508-485-7779 | |
Dr. Karen C. Mitchell, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 340 Maple St, Suite 203, Marlborough, MA 01752 Phone: 508-485-7779 Fax: 508-485-7769 |